PathoQuest, a life sciences spin-out of the Pasteur Institute and the Ecole Nationale Vétérinaire d’Alfort (ENVA), has raised €3.8m ($5m) in series B private equity (PE) funding. Participants in the round were PE firms IDInvest Partners, Kurma Life Science Partners, and Aurinvest. The funding will be used to fuel Paris-based PathoQuest’s trials and technology development.…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
